HomeMarkets Markets Crispr Whipsaws As Wall Street Eyes Its Possible Gene-Editing Blockbuster By news February 22, 2024 0 149 FacebookTwitterPinterestWhatsApp Crispr Therapeutics (CRSP) reported its first profit in 10 quarters on Wednesday, and CRSP stock whipsawed. This is the company’s first earnings …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected156,730FansLike396,312FollowersFollow2,310SubscribersSubscribe Latest Articles Hot Items China Will Soon Lose the Title of “World’s Manufacturer” Markets DOJ: Russia Aimed Propaganda at Gamers, Minorities to Swing 2024 Election Markets OpenAI is looking for new ways to pay its bills Markets More than 90 company executives, 100 law enforcement officials back Harris Markets CTEM: The next frontier in cybersecurity Load more